Kyntra Bio (KYNB) Market Capitalization (2014 - 2026)

Kyntra Bio has disclosed Market Capitalization across 13 years of filings, most recently posting $30.6 million for Q2 2026.

• In Q2 2026, Market Capitalization rose 42.63% year-over-year to $30.6 million; the TTM figure through Jun 2026 stood at $30.6 million (up 42.63% YoY), while the FY2025 annual figure was $35.5 million, down 33.51% from the prior year.
• Market Capitalization came in at $30.6 million for Q2 2026 at Kyntra Bio, up from $27.4 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $1.8 billion in Q1 2023 to a low of $21.4 million in Q2 2025.
• Average Market Capitalization over 5 years is $427.5 million, with a median of $86.2 million recorded in 2023.
• The largest YoY upside for Market Capitalization was 60.79% in 2023 against a maximum downside of 94.2% in 2023.
• Over 5 years, Market Capitalization stood at $1.5 billion in 2022, then slumped by 94.2% to $87.5 million in 2023, then tumbled by 38.96% to $53.4 million in 2024, then plunged by 33.51% to $35.5 million in 2025, then dropped by 13.97% to $30.6 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $30.6 million in Q2 2026, $27.4 million in Q1 2026, and $35.5 million in Q4 2025.